MedPath

Effect of Positive Expiratory Pressure on Right Ventricular Function in Patients With Respiratory Distress Syndrome

Not Applicable
Completed
Conditions
Respiratory Distress Syndrome, Adult
Registration Number
NCT00236262
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

The objective of this study is to analyze by trans-oesophageal echocardiography the effect on the right ventricle of positive expiratory pressure (PEP) level variations with constant plate pressure among patients with syndrome of acute respiratory distress of the adult (SDRA). The assumption tested is that a high level of PEP increases the impedance with the ejection of the right ventricle independently of the level of plate pressure. The effect on the right ventricular preload will be checked via the analysis of the respiratory variability of the diameter of the higher vena cava.

Detailed Description

Background: The ventilatory strategy in patients with Adult Respiratory Distress Syndrome (ARDS) is still controversial concerning the finest level of positive expiratory pressure (PEP). In fact, PEP allows optimisation of lung recruitment and oxygenation. However, high PEP may be detrimental on hemodynamics, notably impairing filling and ejection of the right ventricle (RV). At present, it is not known whether these adverse effects of PEP are independent or not of plateau pressure.

Objectives: The aim of the present study is to explore the effect of PEP variations (with constant plateau pressure) on RV function (assessed using trans-oesophageal echocardiography, TOE) in patients with ARDS. The assumption tested is that a high level of PEP increases the impedance to RV ejection independently of the level of plateau pressure. The effect of PEP on the right ventricular preload will also be checked via the analysis of the respiratory variability of the diameter of superior vena cava. Respiratory system properties will be assessed as follows: alveolar dead space determination using expired CO2, alveolar recruitment calculation using pressure-volume curves.

Methods: The patients are ventilated according to three consecutive strategies (A, B and C), using the same plateau pressure (\<30 cm H2O), but different PEP levels: low PEP in strategy A and high PEP in strategies B and C. In order to maintain a constant plateau pressure, the increase in PEP level in strategies B and C is accompanied by a decrease in tidal volume. This decrease in tidal volume is compensated by an increase in respiratory frequency (strategy B) or a decrease of instrumental dead space by removal of heat and moisture exchanger filter (strategy C).

The first ventilatory strategy tested is "A". After that, the patient is randomised for strategies "B then C", or "C then B". At the end of each strategies the following explorations are performed: TOE, respiratory system pressure-volume curves, expired CO2 analysis, and arterial blood gas analysis.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  1. Intubation and artificial ventilation
  2. Bilateral pulmonary opacities radiological compatible with an organic pulmonary oedema
  3. PaO2/FiO2 report/ratio < 200 mmHg
  4. Not obviously clinical or echocardiographic of rise in the pressure of ventricular filling left
  5. Joint presence of criteria 2, 3 and 4 since less than 72 hours
Read More
Exclusion Criteria
  1. Age <18 years
  2. Pregnancy
  3. Obstructive chronic broncho-pneumonopathy
  4. Suspected or confirmed intracranial hypertension
  5. Pneumothorax
  6. Evolutionary oesophageal pathology
  7. Hemodynamic instability with need of filling vascular or modification of posology of the vasopressors in the 2 hours preceding inclusion
  8. PaO2/FiO2 Report/ratio < 50 mmHg
  9. Amount of adrenaline or noradrenaline higher than 2 mg/hour
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Safety
Efficacy
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

HOPITAL HENRI MONDOR Department of Neurosurgery

🇫🇷

Creteil, France

© Copyright 2025. All Rights Reserved by MedPath